AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ORPEA

Capital/Financing Update Jun 13, 2022

1578_iss_2022-06-13_7218d171-49e6-4ed7-ae0c-83eba7830765.pdf

Capital/Financing Update

Open in Viewer

Opens in native device viewer

ORPEA ANNOUNCES THE CONCLUSION OF A CONCILIATION PROTOCOL WITH ITS CORE BANKING POOL AND ITS APPROVAL BY THE NANTERRE COMMERCIAL COURT

Puteaux, 13 June 2022 (7:30 AM CEST)

In furtherance of the overhaul of the Group's financing strategy, ORPEA is pleased to announce the conclusion and approval of a conciliation protocol with its core banking pool under the key terms of the agreement in principle signed on 12 May 2022.

After having informed and consulted with the relevant employee representative bodies, ORPEA finalized a conciliation protocol on 3 June 2022 for the purposes of implementing the financing arrangements provided for in the agreement in principle signed on 12 May 2022. This protocol was initially signed subject to agreement on the finance and security documentation, which has since been reached with ORPEA's core banking pool.

The key commitments given by ORPEA and its core banking pool under the terms of the protocol and the finance and security documentation are summarized in the annex to this press release.

At ORPEA's request, the Nanterre Commercial Court, in its judgment dated 10 June 2022, approved the conciliation protocol and terminated the conciliation procedure opened in favor of ORPEA on 20 April 2022.

As previously indicated, the new facilities made available under the agreed documents will be made available to the Company incrementally until 31 December 2022 and will be subject to conditions precedent, with a first drawdown of EUR 250m in mid-June.

The financing arrangements under the protocol and credit documentation will enable the ORPEA Group to finance its business, repay existing finance arrangements on time (and without any change to their terms) and fund the necessary investments for its business. The agreement reached is therefore hugely beneficial to the ORPEA Group and to all its stakeholders, including in particular its 255,000 residents and patients, 71,676 employees and creditors.

In compliance with its legal and regulatory obligations, the Company will continue to inform the market of developments through its corporate communications.

========

Annex

The key commitments on ORPEA and the Lenders under the conciliation agreement dated 3 June 2022 and the agreed finance and security documentation

Lenders' key commitments

ORPEA's core banking pool (the "Lenders") have agreed to the following main commitments:

Provision of Credit

The Lenders have undertaken to finance the Group's cash flow requirements by making available the loans referred to as the A1 Loan, A2/A3 Loan, A4 Loan and B Loan in the form of a syndicated loan (together, the "Loans"), which will be signed subject to satisfaction of customary conditions precedent. The key terms of the Loans are summarized as follows:

A1 Loan A2/A3 Loan A4 Loan B Loan C1/C2 Loan
Purpose of
proceeds
To finance or refinance (directly or indirectly),
(i) the general corporate purposes of the
Group (including, without limitation, debt
service and capital expenditure) and (ii) all
fees, costs and expenses relating to the Loans.
(i) finance or
refinance,
(directly or
indirectly) the
payments due
in respect of
the ORPEA
Group's
existing
unsecured
financings
(excluding any
bond
financing) with
the Lenders in
the second
half of 2022 or
their Affiliates
and (ii) finance
all fees, costs
and expenses
relating to the
Loans.
directly or
indirectly, (i)
refinance any of
the ORPEA
Group's existing
unsecured
financing
(excluding any
bond financing)
and (ii) finance
all related fees,
costs and
expenses
Principal
amount (€)
700m 600m 200m 229,389,198.48 A maximum of
1.5bn
Amortisation
profile
One
repayment
at maturity
EUR 100m
repayable on
30/06/2024
One
repayment
at maturity
One
repayment at
maturity
One repayment
at maturity

EUR 100m
repayable on
31/12/2024
EUR 100m
repayable on
30/06/2025
The remainder
repayable on
31/12/2025
Permitted
drawdowns
Maximum
of two
Two (A2 et A3
Loan)
One only Based on the
existing debt
to be
refinanced
To be defined in
the Credit
Agreement
Final
maturity
date
31
December
2023
31 December
2025
30 June
2023
31 December
2025
31 December
2026
Availability
period
From the
Completion
Date to 30
September
2022
A2 Loan: 1-30
September 2022
A3 Loan: from the
Completion Date
to 31 December
2022
From the
Completion
Date to 31
December
2022
From the
Completion
Date to 31
December
2022
From the
Completion
Date to 31
December 2022
Annual
margin
4.00 % to
increase by
2.00 %
from 1
January
2024
4.00 % 3.50 % to
increase by
1.00% from
1 July 2023
4.00 % 5.00%
Security
interests and
privileges
Security interests and conciliation privilege (privilege de
conciliation) under article L. 611-11 of the French Commercial
Code
(i) Security
Interests1 and
(ii) Second
Ranking
Pledges2
, as
defined below.

The Credit Agreement will contain customary events of default (subject to the usual materiality thresholds and cure periods as the case may be), including in particular:

  • Any non-payment default under the Loans;
  • Breach of the minimum consolidated cash commitment described below;
  • Default and cross-acceleration above a cumulative threshold of EUR 40m;

1 For Lenders and their affiliates, as well as for third party creditors participating in A Loans for the C1 Loan.

2 For third party creditors participating in C Loans only.

  • Insolvency and collective proceedings;
  • Enforcement proceedings from a cumulative threshold of EUR 40m;
  • Refusal of certification by auditors of the ORPEA Group's consolidated accounts;
  • Administrative, arbitral, governmental or regulatory disputes that would reasonably be expected to (i) have a material adverse effect or (ii) impact the commitments relating to the disposal of operating and real assets (as described below).

Orpea's Key Commitments

In particular, ORPEA has agreed to the following key commitments:

  • Commitments relating to the disposal of operating and property assets
    • − allocate, as a priority, the net proceeds from the sale of operating assets, up to an aggregate net proceeds amount of EUR 1.2bn in order to reimburse the A1 Loan, the A2/A3 Loan and the B Loan;
    • − dispose of real estate assets for an aggregate gross asset value (excluding rights) of (i) EUR 1bn by 31 December 2023 ; (ii) increasing to EUR 1.5bn by 31 December 2024 ; et (iii) increasing to EUR 2bn by 31 December 2025 ; et
    • − allocate the net proceeds from the disposal of real estate assets to repayment of the A4 Loan, the A2/A3 Loan and the B Loan.
  • Commitment to use certain net proceeds from disposals and subscriptions for the repayment of Loans

ORPEA has also undertaken to allocate certain net proceeds from disposals and subscriptions to compulsory early repayment of the Loans in certain limited circumstances, including:

  • − net proceeds from disposals in the event of any capital increase in its subsidiary Niort 94 ;
  • − net subscription proceeds in the event of new debt issuances on the capital markets; and
  • − net proceeds in the event of obtaining certain financing from the French State or Bpifrance.
  • Commitments to provide security to secure repayment obligations under the Loans

As a guarantee for the pari passu repayment of the amounts due under the Loans, ORPEA has undertaken to grant the following security interests from the first drawdown of one of the Loans:

  • − a 'Dailly' assignment of intra-Group loans financed by drawing on the Loans;
  • − first-ranking pledges on :
    • 100 % of the share capital of CEECSH (the "CEECSH Pledge"); and
    • 100 % of the share capital of ORESC 25 S.à.r.l ("ORESC Pledge") to which the Company will contribute, at the latest on the date of the second drawdown under the Loans

(i.e. excluding the first drawdown of a maximum amount of EUR 250m under the A1 Loan), 100% of the shares of its subsidiary Clinea (the "ORESC Pledge", and together with the CEECSH Pledge, the "Pledges") (the assets being pledged as security representing 25% and 32% of the Group's turnover, respectively). Following certain reorganisations to be carried out within the Group, the pledges over Clinea France and the Group's business in Germany will represent 25% and 16% of consolidated turnover respectively.

The security documentation will most notably provide that in the event of the syndication of C Loans to third party creditors who are participating solely in C Loans, such creditors will benefit as secondranking creditors under the Dailly assignment and will benefit from a second ranking pledge on (i) 100% of the shares of CEECSH and (ii) 100% of the shares of ORESC (the "Second Ranking Pledges").

The security interests (and in particular the first ranking Pledges) will become enforceable if any of the following events of default occur under the Credit Agreement:

  • − As long as the original lenders under the Credit Agreement and any subsequent lenders on an agreed list of potential lenders (in each case together with their affiliates) hold more than 66.2/3% of the outstanding and undrawn commitments at that date under the Loans (other than the C2 Loan) :
  • Non-payment under the Loans;
  • Breach of the minimum consolidated cash commitment described below
  • Insolvency and collective proceedings ;
  • Non-compliance with commitments relating to (i) the disposal or operating and real estate assets described above; or (ii) preservation of assets provided as security ;
  • Default and acceleration (cross-default) above a cumulative threshold of EUR 100m;
  • Refusal by the statutory auditors to certify the ORPEA Group's consolidated financial statements or the existence of reserves on the group's continuity of operations.
  • − If the original lenders under the credit agreement and any subsequent lenders on an agreed list of potential lenders (in each case together with their affiliates) hold more than 66.2/3% of the commitments under the credit agreement hold less than 66.2/3% of the outstanding and undrawn commitments at that date under the Loans (other than the C2 Loan):
    • Non-payment under the Loans;
    • Insolvency and collective proceedings.

The Second Ranking Pledges will only be discharged once the A1, A2/A3, A4, B and C1 Loans have been repaid in the same circumstances (by reference to the commitments under the C2 Loan).

Initiate discussions to support the Group's financing plan

ORPEA has undertaken to enter into discussions with all third party creditors with a view to seeking their support for the Group's financing plan, and in particular their participation in the provision of the C Loans.

Commitment to maintain a consolidated Group cash level

ORPEA has undertaken to maintain a consolidated cash level for the Group of at least EUR 300m on the last day of each quarter beginning on 30 June 2023.

About ORPEA (www.ORPEA-corp.com)

Founded in 1989, ORPEA is one of the world leaders in Dependency care (nursing homes, assisted living, postacute and rehabilitation hospitals, mental health hospitals, home care services)

ORPEA is listed on Euronext Paris (ISIN code: FR0000184798) and is a member of the SBF 120, STOXX 600 Europe, MSCI Small Cap Europe and CAC Mid 60 indices.

Investor Relations Investor Relations Media Relations ORPEA NewCap Image 7 Benoit Lesieur Dusan Oresansky Charlotte Le Barbier

[email protected] [email protected] [email protected]

Investor Relations Director Tel. : +331 44 71 94 94 Tel.: +33 (0)6 78 37 27 60

Caroline Simon Tel. : 06 89 87 61 24 [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.